ABO blood group status and Von Willebrand Factor antigen levels in a cohort of 100 blood donors in an African population



  • IS Akpan,

    Lecturer,Department of Haematology,College of Health Sciences,University of Uyo, Akwa Ibom State

  • EM Essien,

    Department of Haematology,
    College of Health Sciences,University of Uyo, Akwa Ibom State




Von Willebrand Factor (vWF) antigen levels are known to vary widely in healthy individuals.Approximately 30% of the variation in plasma vWF is due to the effect of ABO blood group. The aim of this study was to determine the plasma vWF levels in different ABO blood groups in an African population. Using blood samples of 100 blood donors at the Blood Bank Unit, University of Uyo Teaching Hospital, Uyo, Nigeria, the ABO blood group phenotype was determined by standard tube method while von Willebrand factor antigen (vWF: Ag) was determined by ELISA Method. There were 63 male subjects and 37 female subjects with a mean age of 31.7 6.39 years. The frequency of O, A, B and AB blood groups were 50%, 31%, 16% and 3%, respectively. The mean plasma vWF: Ag concentration of the subjects was 1.38 1.02IU/ml with blood group A having the lowest mean vWF: Ag level (1.087 0.402) followed by group O (1.2896 1.005), followed by group AB (1.687 1.061), followed by group B (2.176 1487) having the highest level. This study reaffirms the well-known notion that ABO blood group influences the plasma level of vWF: Ag and also demonstrates that vWF levels in group O individuals are lower than non-group O individuals in Nigeria, Africa.


Download data is not yet available.


Haberichter SL, Jozwiak MA, Rosenberg JB, Christopherson PA. The von Willebrand factor propeptide (vWFpp) traffics an unrelated protein to storage. Arterioscler Thromb Vasc Biol 2002; 22: 921-6.

Orstavik KH, Magnus P, Reiner H, Berg K, Graham JB. Factor VIII and Factor IX in a twin population: evidence for a major effect of ABO locus on Factor VIII level. Am J Hum Genet 1985; 37: 39-101.

Nitu-Whalley IC, Lee CA, Griffioen A, Pasi KJ. Type I von Willebrand disease – a clinical retrospective study of the diagnosis, the influence of the ABO blood group and the role of the bleeding history. Br J Haematol 2000; 108: 259-64.

Landsteiner K. On agglutination of normal human blood. Transfusion 1961; 1: 5-8.

Cserti CM, Dzik WH. The ABO blood group and plasmodium falciparum malaria. Blood 2007; 110: 2250-8.

Storry JR, Olssom MI. The ABC blood group system revisited, a review and update. lmmunohaematology 2009, 25: 48-59.

Eastlund T. The histo-blood group ABO system and tissue transplantation. Transfusion 1998; 38: 975 -88.

Franchini M. ABO blood group, hypercoagulability, and cardiovascular and cancer risk. Crit Rev Clin Lab Sci 2012; 49: 137-49.

Preston AE, Barr A. The plasma concentration of Factor VIII in the normal population. The effects of age, sex and blood group. Br J Haematol 1964; 10: 238-45.

De Meyer SF, Deckmyn H, Vanhoorelbeke K. Von Willebrand factor to the rescue. Blood 2009; 113: 5049-57.

Sadler JE, Budde U, Elkenboom JC, Favaloro EJ, Hill FG, Holmberg L, et al. The working party on von Willebrand disease classification: Update on the pathophysiocology and classification of von Willebrand disease. J Thromb Haemost 2006; 4: 2103-14.

Nichols WC, Ginsburg D. Willebrand Disease. Medicine 1997; 76: 1-20.

Gill JC, Endress-Brooks T, Bauer PJ, Morkia WI, Montgomery RR. The effect of ABO blood group on the diagnosis of von Willebrand disease. Blood 2004; 69:1691-5.

Levy GG, Ginsburg D. Getting at the variable expressivity of von Willebrand disease. Thromb Haemost 2001; 86: 144-8.

Asuquo l, Okafor I, Usanga A, Isong I. Von Willebrand factor antigen levels in different ABO blood groups in a Nigerian population. International Journal of Biomedical Laboratory Science (IJBLS) 2014; 1: 24-8.

Bain BJ, Lewis SM, Bates I. Basic Haematological Techniques. In: SM Lewis, BJ Bain, I Bates (Eds). Dacie and Lewis Practical Haematology 10th ed Philadelphia Churchill Livingstone. 2006; 36-39.

Matsui T, Titani K, Mizuochi T. Structures of the asparagine-linked oligosaccharide chains of human vWF. Occurrence of blood group A, B and H (0) Structures. J Biol Chem 1992, 267: 8723-31.

Bowen DJ. An influence of ABO blood group on the rate of proteolysis of von Willebrand factor by ADAMTS13. J Thromb Haemost 2003; 1: 33-40.

Harrison RL, Mckee PA. Estrogen stimulates von Willebrand factor production by cultured endothelial cells. Blood 1984; 63: 657-64.

Campos M, Sun W. Genetic determinants of plasma von Willebrand factor antigen levels: target gene SNP and haplotype analysis of ARIC cohort. Blood 2011; 117: 5224-30.

Blann AD. Normal levels of von Willebrand factor antigen in human body fluids. Biologicals 1990; 18: 351-3.

Easton L, FavaloroJW, Soltani S. Reassessment of ABO blood group, sex, and age on laboratory parameters used to diagnose von Willebrand disorder. Potential influence on the diagnosis vs the potential association with risk of thrombosis. Am J Clin Pathol 2006; 124: 910-7.



How to Cite

Akpan, I, Essien, E. . Int Jour of Biomed Res [Internet]. 2016Apr.30 [cited 2020May30];7(4):219-22. Available from: https://ssjournals.net/index.php/ijbr/article/view/3147


Vol. 7 No. 4 (2016): Apr


Original Research Articles

Dr. Jun Ren is a dedicated and experienced registered dietitian and nutritionist who is committed to helping people achieve their health goals through personalized nutrition plans. With a passion for promoting healthy eating habits and preventing chronic diseases, Dr. Ren has been able to assist numerous clients in improving their overall quality of life.

Leave a Comment